Samsrita Labs Ltd.

SAMSRITA

₹21.13

0% (0)

Market Cap

₹31 Cr.

P/E

0.00

Key Ratios

Edit Ratio's

Market cap

31.00 Cr

Prom Holding

49.27 %

ROE (%)

-2.14

ROCE (%)

-2.01

Div Yield (%)

Sales

0.02 Cr

OPM (%)

-4,454.55 %

Debt to Equity

0.18

Edit Ratio's

About

Samsrita Labs is an integrated global Bio-pharmaceutical Company focusing on Stem Cell R&D and… Read more

Low

52W Range

High

Timeline

Key company specific updates

Company Timeline

Custom financial statementNew

Edit rows

In Rs. Cr.	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025

In Rs. Cr.	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Balance sheet
Net Block	—	0.46	0.36	0.26	0.13	0.02	0.01	0.01	0.01	—
Shareholders Funds	—	7.87	11.36	12.20	11.78	11.15	13.23	12.52	12.26	—
Profit & Loss
Operating Profit	—	-0.58	-1.12	-2.44	-2.19	-0.91	-0.40	-0.99	-0.25	—
Net Sales	—	1.28	0.62	2.01	1.43	0.01	0.02	0.02	—	—
Cash flow
Cash from Operating Activity	—	-0.26	-3.32	-2.96	-1.05	-0.34	-0.40	0.66	-0.13	—
Net Capex (est)	—	1.09	1.19	1.55	1.11	0.23	—	—	—	—
Ratios
ROCE (%)	—	-4.97	-7.29	-14.69	-13.21	-6.85	11.30	-5.59	-2.01	—
ROE (%)	—	-10.51	-9.12	-18.34	-16.44	-6.92	11.24	-5.65	-2.14	—

Forensics

6 Yes

Positive for this company

1 Neutral

Neutral for this company

6 No

Negative for this company

4 No Data

Insufficient data to analyse

Accounting & Shareholding

Depreciation Effect

Depreciation accounting is not leading to increase in profits
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Revenue Recognition

Company is converting accounting profit to cash
Promoter Holding

Promoters has been selling shares in the open market over last 90 days
Contingent Liabilities

Unable to calculate due to limited data
Other Income

Unable to calculate due to limited data

Price & Performance

ROE

Net profit margin is responsible for roe increase over last 10 years
Working Capital

Working capital of the company seems to be under control
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Debt

Company might have issues servicing its debt
Share price

Share price has increased over last 10 years but more due to rerating
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong
Capex vs ROCE

Unable to calculate due to limited data
Current vs Historic Valuation

Unable to calculate due to limited data

Revenue mix

Product Wise Break-Up

Peer Comparison

Peer Name	Latest Price	PE	Market cap(Cr)	Prom Holding(%)	YoY Qtly Sales(%)	ROCE (%)	ROE (%)
Samsrita Labs	21.13	0.00	31	49.27	—	-2.01	-2.14
Sinnar Bidi Udyog	779	0.00	31	73.4	-20.94	2.79	4.26
UR Sugar Industries	6.2	76.31	32	26.67	—	4.46	3.07
Asian Tea & Exports	12.6	61.91	31	59.42	33.36	3.5	0.16
Novelix Pharma	33.93	503.69	42	66.56	2,374.61	0.29	2.17
Sarthak Inds	36.79	11.99	34	36.27	1,540.98	3.9	1.68
PALM Jewels	29.78	56.34	31	43.36	-6.57	3.82	2.07
Maharashtra Corpn.	0.49	353.75	30	16.62	-100	0.25	0.25

FAQs on Samsrita Labs Ltd. Business

What does Samsrita Labs do?

Samsrita Labs is integrated global Bio-pharmaceutical Company. The company has been established as an advanced center for research and excellence in the areas of Stem Cell R&D and Therapy, New Drug discovery, Molecular Diagnostics, Stem cell based multi-Specialty Hospital and CRO.

Who are the competitors of Samsrita Labs?

Samsrita Labs major competitors are Sinnar Bidi Udyog, UR Sugar Industries, Asian Tea & Exports, Novelix Pharma, Sarthak Inds, PALM Jewels, Maharashtra Corpn..
Market Cap of Samsrita Labs is ₹31 Crs.
While the median market cap of its peers are ₹31 Crs.

Is Samsrita Labs financially stable compared to its competitors?

Samsrita Labs seems to be less financially stable compared to its competitors.
Altman Z score of Samsrita Labs is 0 and is ranked 6 out of its 8 competitors.

View FAQ's On Shareprice

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Samsrita Labs Ltd.

Samsrita Labs Ltd.

Key Ratios

About

Timeline

Company Timeline

6 Yes

1 Neutral

6 No

4 No Data

Accounting & Shareholding

Depreciation Effect

Pledge

Retail Holding

Revenue Recognition

Promoter Holding

Contingent Liabilities

Other Income

Price & Performance

ROE

Working Capital

Balance Sheet Strength

Debt

Share price

Sales Growth

Margin Stability

ROCE Strength

Capex vs ROCE

Current vs Historic Valuation

Product Wise Break-Up

UNLOCK PREMIUM

What does Samsrita Labs do?

Who are the competitors of Samsrita Labs?

Is Samsrita Labs financially stable compared to its competitors?

SIGN UP FOR FREE